ES8302455A1 - Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica. - Google Patents

Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica.

Info

Publication number
ES8302455A1
ES8302455A1 ES509234A ES509234A ES8302455A1 ES 8302455 A1 ES8302455 A1 ES 8302455A1 ES 509234 A ES509234 A ES 509234A ES 509234 A ES509234 A ES 509234A ES 8302455 A1 ES8302455 A1 ES 8302455A1
Authority
ES
Spain
Prior art keywords
penicillin derivative
matter
composition
lyophilized
lyophilized preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES509234A
Other languages
English (en)
Spanish (es)
Other versions
ES509234A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8302455(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8302455A1 publication Critical patent/ES8302455A1/es
Publication of ES509234A0 publication Critical patent/ES509234A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ES509234A 1981-03-26 1982-02-01 Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica. Granted ES509234A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26

Publications (2)

Publication Number Publication Date
ES8302455A1 true ES8302455A1 (es) 1982-12-16
ES509234A0 ES509234A0 (es) 1982-12-16

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES509234A Granted ES509234A0 (es) 1981-03-26 1982-02-01 Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica.

Country Status (23)

Country Link
JP (1) JPS57159708A (ja)
AT (1) AT395533B (ja)
AU (1) AU549784B2 (ja)
BE (1) BE892541A (ja)
CA (1) CA1209477A (ja)
CH (1) CH652306A5 (ja)
DE (2) DE3208505A1 (ja)
DK (1) DK157976C (ja)
ES (1) ES509234A0 (ja)
FR (1) FR2502624B1 (ja)
GB (1) GB2095551B (ja)
GR (1) GR78386B (ja)
HK (1) HK39189A (ja)
HU (1) HU186489B (ja)
IE (1) IE52936B1 (ja)
IL (1) IL64924A (ja)
IT (1) IT1147916B (ja)
LU (1) LU84031A1 (ja)
NL (1) NL192664C (ja)
NZ (1) NZ199632A (ja)
PL (1) PL130564B1 (ja)
SE (1) SE453153B (ja)
ZA (1) ZA82605B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) * 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
BRPI0415531B8 (pt) 2003-10-23 2021-05-25 Otsuka Pharma Co Ltd formulação de aripiprazol injetável estéril de liberação controlada e método para a sua preparação
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
AR067747A1 (es) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd Metodos para producir suspension de aripiprazol y formulacion liofilizada
CN114200057A (zh) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 一种可替代标准溶液的抗生素类药物固体混合标准物质的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (de) * 1971-03-11 1974-03-15 Hoffmann La Roche Verfahren zur herstellung von penicilloinsaeurederivate.
JPS5817728B2 (ja) * 1973-11-20 1983-04-09 山之内製薬株式会社 アンピシリンナトリウムエン ノ セイホウ
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (de) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Verfahren zur Herstellung von Natriumampicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
NL192664B (nl) 1997-08-01
SE8200591L (sv) 1982-09-27
NL192664C (nl) 1997-12-02
BE892541A (fr) 1982-09-20
CH652306A5 (de) 1985-11-15
AT395533B (de) 1993-01-25
DE3208505A1 (de) 1982-10-21
NL8201251A (nl) 1982-10-18
GB2095551B (en) 1984-10-03
SE453153B (sv) 1988-01-18
IT8248034A0 (it) 1982-03-19
NZ199632A (en) 1985-07-12
DE19375106I2 (de) 2006-02-16
FR2502624A1 (fr) 1982-10-01
IT1147916B (it) 1986-11-26
DK48382A (da) 1982-09-27
HU186489B (en) 1985-08-28
IE52936B1 (en) 1988-04-13
FR2502624B1 (fr) 1985-10-25
GB2095551A (en) 1982-10-06
AU549784B2 (en) 1986-02-13
AU7986582A (en) 1982-09-30
JPH0219804B2 (ja) 1990-05-07
DK157976C (da) 1990-08-27
PL235509A1 (ja) 1982-12-20
JPS57159708A (en) 1982-10-01
CA1209477A (en) 1986-08-12
IE820703L (en) 1982-09-26
IL64924A0 (en) 1982-04-30
DK157976B (da) 1990-03-12
DE3208505C2 (ja) 1991-11-28
ZA82605B (en) 1982-12-29
IL64924A (en) 1985-07-31
ATA92982A (de) 1992-06-15
GR78386B (ja) 1984-09-26
PL130564B1 (en) 1984-08-31
LU84031A1 (de) 1982-07-08
HK39189A (en) 1989-05-19
ES509234A0 (es) 1982-12-16

Similar Documents

Publication Publication Date Title
HU906341D0 (en) Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
SE8402551L (sv) Cinnamoylmoranolin-derivat
IL82209A0 (en) Insulin preparation
DE2961284D1 (en) Tetrahydropyridinyl indole derivatives and their salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
DE2966142D1 (en) Quinolein-3-carboxylic acid derivatives, process for their preparation, their use in medicines and pharmaceutical compositions containing them
GB1298494A (en) Phenylethanolamine derivatives
PT75217B (de) Magenvertragliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
ES8302455A1 (es) Procedimiento para preparar una unidad de dosificacion parentepal farmaceutica.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
IE790194L (en) Pharmaceutical formulation
KR920702225A (ko) 약학 조성물
JPS5679622A (en) Antitumor pharmaceutical
DE2963545D1 (en) Pharmaceutical composition containing all-e- or 13-z-7,8-dehydro-retinoic acid and process for its preparation
JPS6438026A (en) Glucide absorption inhibitor
GB1460325A (en) Pharmaceutical composition intended for relieving pain and producing analgesia
IE34648L (en) Pharmaceutical composition containing garcinia acid
SE8204792L (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
JPS646214A (en) Remedy for ulcerative colonopathy
GB2120529A (en) Methods of preparing and using intravenous nutrient compositions
SE8106498L (sv) Kvaternera salter av n,n3-di(beta-brompropionyl)-n1,n2-dispirotripiperazinium, forfarande for framstellning av desamma och lekemedelspreparat innehallande desamma
SU1120394A1 (ru) Способ моделировани атрио-вентрикул рного блока сердца
BE787809A (fr) Derives de l'acide phenylacetique, leur procede de preparation et composition therapeutique les contenant
FR2554819B1 (fr) Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
KR830004848A (ko) 페니실린 유도체의 동견 건조물로 된 주사용량 단위물 제조방법